Skip to content

13F-HR filed by Artal Group S.A.

Artal Group S.A. filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-09, with 119 holding rows worth $6,629,762,000.

Accession
0001053906-18-000005
Filed
2018-02-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 121 entries on the cover page, a total value of $6,629,762,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,629,762,000 with VALUE read as thousands by filing date, 13F file number 028-15027. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BLUE BUFFALO PET PRODS INC09531U102COM87,460,875$2,867,842,000thousands by filing date
WEIGHT WATCHERS INTL INC948626106COM29,443,300$1,303,749,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK58,274,650$575,754,000thousands by filing date
Bank of America Corp060505104COM5,800,000$171,216,000thousands by filing datecall
International Business Machines Corporation459200101COM800,000$122,736,000thousands by filing datecall
Citigroup Inc.172967424COM1,500,000$111,615,000thousands by filing datecall
Wells Fargo & Company949746101COM1,500,000$91,005,000thousands by filing datecall
Gilead Sciences,Inc.375558103COM1,250,000$89,550,000thousands by filing datecall
ALEXION PHARMACEUTICALS INC015351109COM650,000$77,734,000thousands by filing datecall
NEKTAR THERAPEUTICS640268108COM1,100,000$65,692,000thousands by filing datecall
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock450,000$57,173,000thousands by filing date
Bristol-Myers Squibb Company110122108COM900,000$55,152,000thousands by filing datecall
Goldman Sachs Group,Inc.38141G104COM200,000$50,952,000thousands by filing datecall
INCYTE CORP COM45337C102Stock500,000$47,355,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS200,000$34,486,000thousands by filing datecall
SPDR SER TR78464A870S&P BIOTECH400,000$33,948,000thousands by filing datecall
ALLERGAN PLCG0177J108SHS200,000$32,716,000thousands by filing datecall
ACCELERON PHARMA INC00434H108COM750,000$31,830,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM200,000$29,972,000thousands by filing datecall
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR300,000$29,316,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM500,000$28,585,000thousands by filing date
BLUEBIRD BIO INC09609G100COM150,000$26,715,000thousands by filing date
Morgan Stanley617446448COM500,000$26,235,000thousands by filing datecall
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock200,000$25,410,000thousands by filing datecall
NEKTAR THERAPEUTICS640268108COM400,000$23,888,000thousands by filing date
INCYTE CORP COM45337C102Stock250,000$23,678,000thousands by filing datecall
AMICUS THERAPEUTICS INC03152W109COM1,400,000$20,146,000thousands by filing datecall
NEUROCRINE BIOSCIENCES INC64125C109COM250,000$19,398,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock1,500,000$19,200,000thousands by filing date
MEDICINES CO584688105COM700,000$19,138,000thousands by filing datecall
REGENERON PHARMACEUTICALS COM75886F107Stock50,000$18,798,000thousands by filing datecall
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock1,000,000$18,100,000thousands by filing date
BRIGHTHOUSE FINL INC10922N103COM300,000$17,592,000thousands by filing datecall
Amgen Inc.031162100COM100,000$17,390,000thousands by filing datecall
AVEXIS INC05366U100COM150,000$16,601,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM350,000$15,999,000thousands by filing datecall
CELGENE CORP151020104COM150,000$15,654,000thousands by filing datecall
ANAPTYSBIO INC032724106COM150,000$15,108,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM1,000,000$14,390,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM350,000$13,773,000thousands by filing date
Accelerate Diagnostics00430H102COM500,000$13,100,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW400,000$12,708,000thousands by filing date
METLIFE INC COM59156R108Stock250,000$12,640,000thousands by filing datecall
ARGENX SE SPONSORED ADR04016X101ADR200,000$12,628,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM75,000$12,353,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM150,000$10,200,000thousands by filing datecall
BIOMARIN PHARMACEUTICAL INC09061G101COM100,000$8,917,000thousands by filing datecall
BLUEBIRD BIO INC09609G100COM50,000$8,905,000thousands by filing datecall
REGENXBIO INC75901B107COM250,000$8,313,000thousands by filing date
TESARO INC881569107COM100,000$8,287,000thousands by filing date
AGENUS INC00847G705COM NEW2,500,255$8,151,000thousands by filing date
ZTO EXPRESS CAYMAN INC98980A105SPONSORED ADS A500,000$7,925,000thousands by filing datecall
DENALI THERAPEUTICS INC COM24823R105Stock500,000$7,820,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK516,879$7,748,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK300,000$7,680,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM100,000$7,541,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock150,000$7,302,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS500,000$7,300,000thousands by filing datecall
CLOVIS ONCOLOGY INC189464100COM100,000$6,800,000thousands by filing date
AC IMMUNE SAH00263105SHS500,000$6,400,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock500,000$6,400,000thousands by filing datecall
AUDENTES THERAPEUTICS INC.05070R104Common Stock200,000$6,250,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO1,900,000$6,128,000thousands by filing date
VALE S A91912E105SPONSORED ADS500,000$6,115,000thousands by filing datecall
ALDER BIOPHARMACEUTICALS INC014339105COM500,000$5,725,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM100,000$5,717,000thousands by filing datecall
MEDICINES CO584688105COM200,000$5,468,000thousands by filing date
SYNLOGIC INC87166L100COM550,000$5,335,000thousands by filing date
VITAL THERAPIES INC92847R104COM875,000$5,206,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK50,000$4,943,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM250,000$4,805,000thousands by filing date
FREEPORT MCMORAN INC CL B35671D857Stock250,000$4,740,000thousands by filing datecall
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR700,000$4,676,000thousands by filing date
ZAFGEN INC98885E103COM1,000,000$4,620,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM100,000$4,571,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM250,000$4,198,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM350,000$4,113,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW200,000$3,740,000thousands by filing date
Bowater Inc09066L105COMMON STOCKS1,557,050$3,348,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock400,000$3,280,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock92,078$3,232,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW100,000$3,177,000thousands by filing datecall
STEMLINE THERAPEUTICS INC85858C107COM200,000$3,120,000thousands by filing date
VERASTEM INC92337C104COM1,000,000$3,070,000thousands by filing date
SERES THERAPEUTICS INC81750R102COM300,000$3,042,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock150,000$3,039,000thousands by filing date
CHEMOCENTRYX INC16383L106COM500,000$2,975,000thousands by filing date
CELLECTIS ADS15117K103COM100,000$2,915,000thousands by filing date
CORBUS PHARMACEUTICALS HLDGS21833P103COM400,000$2,840,000thousands by filing date
ACHAOGEN INC004449104COM250,000$2,685,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock500,000$2,455,000thousands by filing date
CHIMERIX INC COM16934W106Stock500,000$2,315,000thousands by filing date
XENCOR INC98401F105COMMON STOCK100,000$2,192,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM750,000$2,160,000thousands by filing date
TESARO INC881569107COM25,000$2,072,000thousands by filing datecall
JOUNCE THERAPEUTICS INC481116101COM150,000$1,913,000thousands by filing date
MACROGENICS INC556099109COM100,000$1,900,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM100,000$1,825,000thousands by filing date
ATYR PHARMA INC002120103COM500,000$1,750,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q101COM200,000$1,632,000thousands by filing date
NEWLINK GENETICS CORP651511107COM200,000$1,622,000thousands by filing datecall
KRYSTAL BIOTECH INC COM501147102Stock150,000$1,578,000thousands by filing date
EDITAS MEDICINE INC28106W103COM50,000$1,537,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock100,000$1,530,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock251,300$1,520,000thousands by filing date
CHINOOK THERAPEUTICS INC.00739L101Common Stock200,000$1,500,000thousands by filing date
RHYTHM PHARMACEUTICALS INC76243J105COM50,000$1,453,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM150,000$1,314,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock50,000$1,174,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock150,000$1,088,000thousands by filing date
MIRAGEN THERAPEUTICS INC60463E103COM100,000$1,043,000thousands by filing date
TOCAGEN INC888846102COM100,000$1,025,000thousands by filing date
NANTKWEST INC63016Q102COM225,000$1,010,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM350,336$995,000thousands by filing date
CALITHERA BIOSCIENCES INC COM NEW13089P101Stock100,000$835,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW256,400$800,000thousands by filing date
ONCOCYTE CORP68235C107COM150,000$698,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK500,000$620,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock150,000$424,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001053906-18-000005this filing2018-02-09acceptance time not in the bulk data set